April 4 (Reuters) - Proteostasis Therapeutics Inc:
* PROTEOSTASIS THERAPEUTICS RECEIVES FDA FAST TRACK DESIGNATION FOR TRIPLE COMBINATION PROGRAM IN PATIENTS WITH CYSTIC FIBROSIS
* FDA GRANTED FAST TRACK DESIGNATION FOR CO’S TRIPLE COMBINATION PROGRAM FOR TREATMENT OF CYSTIC FIBROSIS Source text for Eikon: Further company coverage: